Highly Diversified Pandoraea pulmonicola Population during Chronic Colonization in Cystic Fibrosis

Chloé Dupont1, Fabien Aujoulat1, Raphaël Chiron2

  • 1Equipe Pathogènes Hydriques, Santé, Environnements, UMR 5569 Hydrosciences Montpellier, U.F.R des Sciences Pharmaceutiques et Biologiques and Université Montpellier, Montpellier, France.

Frontiers in Microbiology
|October 24, 2017
PubMed

Insights

Pandoraea pulmonicola exhibits significant genomic and phenotypic diversity in cystic fibrosis airways. This bacterial adaptability may be a strategy for persistent colonization in the challenging CF respiratory tract environment.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Environmental bacteria like Pandoraea spp. are opportunistic pathogens in cystic fibrosis (CF).
  • Persistent colonization of the CF respiratory tract (CFRT) by bacteria like Pseudomonas aeruginosa involves adaptive evolution.
  • The persistence and evolution of Pandoraea in the CFRT are poorly understood.

Purpose of the Study:

  • To investigate the genomic and phenotypic traits of Pandoraea pulmonicola isolates from a single CF patient over time.
  • To correlate bacterial evolution with changes in the CFRT microbiota and patient clinical status.
  • To explore Pandoraea pulmonicola's adaptive strategies for persistence in the CFRT.

Main Methods:

  • Analysis of 31 Pandoraea pulmonicola isolates from 18 sputum samples over 7 years.
  • Genome dynamics assessed by pulsed-field gel electrophoresis and ERIC-PCR fingerprinting.
  • Phenotypic characterization including antimicrobial susceptibility, motility, biofilm production, and C. elegans virulence.

Main Results:

  • High variability observed in genomic and phenotypic traits, resulting in 24 distinct patterns among 31 clonally related isolates.
  • Genomic modifications coincided with shifts in CFRT microbiota composition and severe patient exacerbations.
  • Intra- and inter-sample diversity of P. pulmonicola suggests an adaptive strategy for host persistence.

Conclusions:

  • Pandoraea pulmonicola populations in the CF respiratory tract display significant diversification.
  • This diversity may represent a patho-adaptive strategy enabling long-term persistence in the fluctuating CFRT environment.
  • Further research is needed to understand the clinical implications of Pandoraea diversity in CF patients.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
922
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
559
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.7K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K